{"id":"W4299117194","doi":"","title":"Trastuzumab (T) and everolimus (E) pharmacokinetics (PK) in HER2 positive (+) primary breast cancer (BC) patients (pts): Unicancer RADHER trial results","year":2013,"lang":"en","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Trastuzumab; Everolimus; Medicine; Breast cancer; Pharmacokinetics; Oncology; Internal medicine; Cancer; Gynecology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001026145,0.0004898228,0.0013457,0.0001162485,0.0001237874,0.0006161128,0.0002851186,0.0004593285,0.00386303],"category_scores_gemma":[0.001505776,0.0001706245,0.0007500742,0.0002493385,0.0002734577,0.0005503097,0.0002843791,0.001112132,0.0005067021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005607396,"about_ca_system_score_gemma":0.0006365269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005860237,"about_ca_topic_score_gemma":0.001360533,"domain_scores_codex":[0.999678,0.000206552,0.0000136441,0.00004282855,0.0000207814,0.00003831695],"domain_scores_gemma":[0.999587,0.0001279031,0.00008505125,0.00004968041,0.00002324241,0.0001271238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8147646,0.003082368,0.007086385,0.0008220624,0.001762718,0.0002079441,0.0001338977,0.003907042,0.008057626,0.0004155697,0.01134894,0.1484109],"study_design_scores_gemma":[0.7432438,0.1425305,0.06141989,0.0002803924,0.007644021,0.001138217,0.0001511891,0.004756285,0.007403567,0.002155408,0.0291825,0.00009420674],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858575,0.005979766,0.00035904,0.001137952,0.00009074368,0.0002044219,0.002354553,0.00009147895,0.003924526],"genre_scores_gemma":[0.9871952,0.003344746,0.0007399162,0.0006309344,0.0001549655,0.0003128784,0.002977916,0.0000551723,0.004588343],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00386303,"threshold_uncertainty_score":0.01292312,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02166874102913106,"score_gpt":0.3020995897932127,"score_spread":0.2804308487640816,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}